GRIDS Capital

The EGI platform from the Foundation is designed to speed up all phases of the product development cycle, from design and research to production and documentation, enabling engineers to create better products more quickly and effectively.

Atrandi Biosciences is a privately held biotechnology company focused on advancing single-cell technology, particularly through next-generation single-cell eukaryotic DNA sequencing. This innovative method enables detailed analysis of genomic alterations and cellular heterogeneity. The company develops proprietary microfluidics technology, which includes hardware systems, consumables, and software services. These tools facilitate user-friendly workflows that empower researchers to explore complex biological systems at the single-cell and single-molecule levels. By enhancing the capabilities of single-cell analysis, Atrandi Biosciences aims to support scientific advancements in the understanding of biology and disease.

Passkey Therapeutics is pioneering a new class of medicines, Synergistic Multifunctional Therapeutics (SMThs). It is designed to address complex diseases by targeting rare combinations of proteins that work together.

Plotlogic is a global technology company focused on enhancing the efficiency of mine operations through advanced AI and sensor-driven solutions. Its yield uplift platform provides real-time, autonomous, and non-invasive characterization of raw materials, allowing mine operators to accurately assess the location and properties of every rock within a mine. This technology enables clients to improve ore recovery, minimize dilution, and reduce operational costs while also decreasing carbon emissions and environmental impact. By delivering precise insights into mineral composition and location, Plotlogic supports the critical mineral industry in maximizing yield and sustainability.

Hedera Dx is a healthcare venture based in Epalinges, Vaud, established on July 1, 2021, that develops a liquid biopsy solution aimed at simplifying tumor profiling for hospital labs. This technology provides clinicians with a streamlined experience for accessing information and conducting liquid biopsy tests, which are essential for early cancer detection, therapy selection, and monitoring recurrence. By addressing challenges such as IVD compliance, privacy infrastructure, and validation, Hedera Dx enhances the efficiency of existing software workflows while offering key capabilities that were previously lacking. The company's innovations provide medical professionals with new opportunities to reduce cancer mortality and healthcare costs.

BigHat Biosciences, Inc. is a biotechnology company based in San Carlos, California, founded in 2019. The company specializes in developing an automated platform that combines a wet laboratory with artificial intelligence and machine learning techniques for the production and characterization of antibodies. This innovative platform empowers drug developers to engineer antibodies and other therapeutic proteins with improved biophysical properties and complex functions. By leveraging AI-guided design capabilities, BigHat aims to create safer and more effective treatments for patients facing challenging diseases, thereby advancing the field of biotherapeutics.

FORT Robotics, Inc. specializes in developing and manufacturing wireless control systems designed for dangerous machines. The company produces industrial wireless remote machine control systems and safety devices that enhance productivity while preventing accidents. Key offerings include a wireless emergency stop system, which allows users to quickly shut down any machinery from a safe distance, and a vehicle safety controller that acts as a safety receiver, wireless E-Stop system, and CAN bus bridge. These devices are utilized in various sectors, including construction, agriculture, manufacturing, warehousing, transportation, and mobile robotics. Based in Philadelphia, Pennsylvania, FORT Robotics aims to unlock the full potential of automation by providing a safety and security platform that accelerates development and reduces risks associated with autonomous systems.

CloudNC Ltd. is a London-based company that specializes in developing software to automate the programming of computerized numerical control (CNC) milling machines. Established in 2015, CloudNC aims to modernize the manufacturing industry by creating advanced software that allows factories to autonomously produce precision parts, which are essential for various aspects of modern life, including automotive, aerospace, and electronics. The company's technology transforms CNC milling machines into user-friendly devices that require minimal human intervention, thus enhancing efficiency, reducing lead times, and increasing scalability for manufacturers. By focusing on automation and sustainability, CloudNC seeks to revolutionize the manufacturing process, making it ten times more efficient and positioning itself at the forefront of a $150 billion industry.

ALICE Technologies develops an AI-powered construction simulation platform designed to enhance project planning and execution in the construction industry. This platform utilizes artificial intelligence to analyze complex building requirements, generate efficient schedules, and adapt these schedules as construction progresses. By providing detailed schedules and resource allocations, the platform helps contractors and project owners effectively plan, bid, and build, leading to significant reductions in construction times and labor costs. For a typical $500 million construction project, ALICE Technologies can save approximately $30 million. The company collaborates with key players in the infrastructure and commercial construction sectors, including Parsons, HDCC, and Kajima Corporation, to optimize construction processes and improve project outcomes.

Dusty Robotics, Inc. specializes in providing automated layout services for the construction industry through its innovative robot-powered tools. Founded in 2018 and based in Mountain View, California, the company offers the FieldPrinter, which translates digital building information modeling (BIM) designs into accurate, constructible layouts directly on construction-site floors. By synchronizing BIM information with on-site requirements, Dusty Robotics eliminates manual steps in the workflow, enhancing efficiency and reducing waste in labor and materials. The company serves a diverse range of clients, including owners, general contractors, subcontractors, and builders, aiming to streamline the design-build-operate lifecycle in construction projects.

Hedera Dx is a healthcare venture based in Epalinges, Vaud, established on July 1, 2021, that develops a liquid biopsy solution aimed at simplifying tumor profiling for hospital labs. This technology provides clinicians with a streamlined experience for accessing information and conducting liquid biopsy tests, which are essential for early cancer detection, therapy selection, and monitoring recurrence. By addressing challenges such as IVD compliance, privacy infrastructure, and validation, Hedera Dx enhances the efficiency of existing software workflows while offering key capabilities that were previously lacking. The company's innovations provide medical professionals with new opportunities to reduce cancer mortality and healthcare costs.

Plotlogic is a global technology company focused on enhancing the efficiency of mine operations through advanced AI and sensor-driven solutions. Its yield uplift platform provides real-time, autonomous, and non-invasive characterization of raw materials, allowing mine operators to accurately assess the location and properties of every rock within a mine. This technology enables clients to improve ore recovery, minimize dilution, and reduce operational costs while also decreasing carbon emissions and environmental impact. By delivering precise insights into mineral composition and location, Plotlogic supports the critical mineral industry in maximizing yield and sustainability.

CloudNC Ltd. is a London-based company that specializes in developing software to automate the programming of computerized numerical control (CNC) milling machines. Established in 2015, CloudNC aims to modernize the manufacturing industry by creating advanced software that allows factories to autonomously produce precision parts, which are essential for various aspects of modern life, including automotive, aerospace, and electronics. The company's technology transforms CNC milling machines into user-friendly devices that require minimal human intervention, thus enhancing efficiency, reducing lead times, and increasing scalability for manufacturers. By focusing on automation and sustainability, CloudNC seeks to revolutionize the manufacturing process, making it ten times more efficient and positioning itself at the forefront of a $150 billion industry.

MontyCloud Inc. is a technology company that specializes in creating an artificial intelligence-driven software-as-a-service (SaaS) platform for managing and governing cloud infrastructure, applications, and services. Founded in 2018 and located in Woodinville, Washington, MontyCloud offers solutions that simplify the management of cloud services, automate maintenance tasks, and streamline governance and compliance processes. Its platform employs an event-driven architecture, integrating AI and machine learning to provide automation and actionable insights. The company addresses key areas such as cloud cost management, security, compliance automation, and disaster recovery, enabling clients to achieve consistent, policy-driven management across diverse cloud environments.

Ingenuity Foods, Inc.

Endpoint Health, Inc. is a precision immunology company based in Palo Alto, California, with additional offices in Michigan and Illinois. Founded in 2018, the company focuses on researching and developing therapies that integrate therapeutics, companion diagnostics, and artificial intelligence. Its mission is to enhance patient outcomes, particularly for individuals suffering from critical illnesses such as sepsis, acute respiratory distress syndrome, and COVID-19. By utilizing its proprietary AI-powered platform, OMNAI, Endpoint Health aims to identify and match effective therapies with patients who are most likely to benefit from them, moving beyond traditional one-size-fits-all approaches in drug development. Through this strategy, the company seeks to deliver personalized treatments that can significantly improve the health outcomes of patients with autoimmune and inflammatory conditions.

Halter Limited, founded in 2016 and based in Morrinsville, New Zealand, specializes in developing GPS-enabled, solar-powered tracking devices for livestock. The company manufactures innovative collars designed for cows, allowing farmers to monitor and guide their animals across pastures. Halter's technology enables virtual fencing, helping farmers optimize productivity while promoting sustainable farming practices. By enhancing the management of livestock, Halter aims to improve agricultural efficiency and animal welfare, contributing to the overall sustainability of pasture-based farming.

Mesodyne is an engineering and manufacturing company focused on innovative electricity generation solutions, particularly through its patented LightCell technology, which converts various fuels into electricity using light. Founded in 2018 by Drs. Veronika Stelmakh and Walker Chan, the company aims to deliver portable and reliable power generation systems to military and commercial users. Mesodyne's compact power generators enhance the endurance of small autonomous systems, offering efficient and long-lasting energy sources that bridge the gap between traditional batteries and internal combustion engines. This technology is designed to alleviate the burden on dismounted warfighters and emergency responders while extending the operational range of unmanned vehicles, wearables, and other equipment.

Loft Orbital Solutions Inc. is a company based in San Francisco, California, that provides comprehensive services for the deployment and operation of customer payloads in space. Established in 2017, Loft Orbital specializes in operating microsatellites and offers an end-to-end solution that includes satellite platform integration, launch booking, and operational management. The company simplifies the satellite deployment process by utilizing a standardized satellite bus and a suite of software tools, thereby reducing costs and accelerating the timeline to orbit. Additionally, Loft Orbital addresses financial and regulatory challenges by providing solutions for licensing, insurance, and financing, allowing customers to concentrate on their mission objectives rather than the technical complexities of satellite engineering.

Culture Biosciences, Inc. is a biomanufacturing company based in South San Francisco, California, that offers a cloud-based platform for scientists to conduct, monitor, and analyze bioreactor experiments. Founded in 2016, the company focuses on automating bioprocesses to help biotech firms optimize their manufacturing processes and expedite product development. By utilizing robotic sample handling and cloud data monitoring, Culture Biosciences enhances the efficiency of fermentation and bioreactor operations, allowing researchers to achieve results more rapidly than with traditional methods.

Syntegra operates a synthetic healthcare data platform designed to enhance patient care and clinical outcomes through the use of machine learning. By generating validated synthetic data that preserves the statistical properties of real healthcare data while ensuring privacy, Syntegra addresses the growing barriers to clinical data access faced by healthcare systems and data aggregators. The platform allows users to conduct analytics, build predictive models, and create synthetic control groups for clinical trials without compromising patient confidentiality or violating regulatory compliance. Data training occurs on secure, non-identifiable datasets, ensuring that no personal information is exposed. Additionally, Syntegra employs rigorous validation and benchmarking methods to ensure the integrity of its data derivatives. The company's scalable solution accommodates various data types, including images and sensor streams, which will be securely integrated into its data lake over time. Led by a team of experienced entrepreneurs and academic experts in medicine and data science, Syntegra is positioned to drive innovation in healthcare analytics.

Fauna Bio Incorporated is a biotechnology company based in San Francisco, California, founded in 2018. It specializes in developing a cross-mammal drug discovery platform aimed at treating human diseases, including heart disease and neurodegenerative disorders. By studying the mechanisms that allow certain animals, such as hibernating and deep-diving species, to withstand extreme conditions, Fauna Bio seeks to uncover insights that can enhance human health. The company utilizes animal genomics, transcriptomics, metabolomics, and proteomics data from a diverse range of species to identify novel drug targets and facilitate pre-clinical and early clinical testing of new therapeutics. Through its innovative approach, Fauna Bio aims to improve recovery from serious medical events like trauma, heart attacks, and strokes.

Heliogen, Inc. is a clean energy technology company based in Pasadena, California, founded in 2013. It specializes in using concentrated solar power to produce renewable fuels such as hydrogen and syngas, aiming to eliminate reliance on fossil fuels in heavy industry. The company has developed innovative systems, including HelioMax, a closed-loop control system for electricity generation and process heat applications, and HelioHeat, which provides carbon-free, ultra-high-temperature heat for sectors like cement, refining, and mining. Heliogen’s AI-enabled modular technology enables the cost-effective delivery of continuous carbon-free energy in the form of heat, power, or green hydrogen, marking a significant advancement in sustainable energy solutions.

Stable provides software solutions designed to assist electric vehicle (EV) fleets and charging providers in efficiently planning and managing their charging infrastructure. Founded in 2016 and based in San Francisco, the company offers a siting and forecasting platform that utilizes a proprietary machine learning model to predict site utilization and optimize the placement and sizing of charging stations. By consolidating essential data and insights, Stable enables customers to make informed decisions regarding the deployment of charging stations, ensuring that they are installed in locations where they are most needed.

Flex Logix, founded in 2014 and based in Mountain View, California, specializes in semiconductor and software solutions that enable the embedding of field-programmable gate arrays (FPGAs) of various sizes within integrated circuits. The company's innovative technology allows chips to change their configuration even after they have been shipped, providing chip designers with the flexibility to reprogram essential register-transfer levels at any time. Flex Logix generates revenue through licensing fees for design files and tools, an annual fee for the ongoing use of its EFLX Compiler, and royalties based on usage.

Senti Biosciences is a clinical-stage biotechnology company specializing in synthetic biology and gene circuit engineering for therapeutic purposes. The company employs its Gene Circuits platform to develop innovative therapies that enhance precision in targeting cancer cells while avoiding damage to healthy cells. Senti Bio's approach involves the use of allogeneic chimeric antigen receptor natural killer (CAR-NK) cells that incorporate its gene circuit technologies, aimed at addressing various oncology indications. Among its product candidates are SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to selectively eliminate cancer cells without harming healthy bone marrow, and SENTI-301A, which targets hepatocellular carcinoma. Senti Biosciences aims to provide effective treatment options for difficult-to-treat diseases through advanced cell and gene therapies.

Momentus Inc. is a commercial space company based in Santa Clara, California, founded in 2017. The company specializes in providing water-powered transportation services for spacecraft and aims to offer a range of in-space infrastructure services. These services include in-space transportation, hosted payloads, and in-orbit servicing, facilitated by its planned transfer and service vehicles. Momentus is developing an innovative water plasma-based propulsion system to enable efficient movement of satellites and payloads between orbits. By focusing on space transportation, satellite services, and in-orbit servicing, Momentus positions itself as a key player in the evolving space economy.

nTopology, Inc. is an engineering software company that develops tools for manufacturing, focusing on design, simulation, and advanced manufacturing processes. Its flagship product, nTopology, allows engineers to create lightweight and optimized parts tailored to their functional requirements. The platform includes features such as Lightweighting, Architected Materials, Topology Optimization, Additive Manufacturing, and Design Analysis, which help eliminate geometry bottlenecks and enhance collaboration among teams. nTopology serves various industries, including aerospace and defense, medical, automotive, consumer products, and education. Founded in 2013 and headquartered in New York, the company aims to streamline workflows and integrate synthesized geometry with simulation data to produce manufacturing-ready models.

Dishcraft Robotics, Inc. develops and manufactures advanced robotic systems for commercial kitchens, focusing on efficient dishwashing solutions. The company's technology features a rotating scrubber head that cleans each dish individually and employs computer vision for rapid inspection of food residue. Dishcraft's service, known as Dishcraft Daily, offers clean-dish delivery, enhancing productivity and minimizing waste in corporate kitchens and restaurants. Founded in 2015 and headquartered in San Carlos, California, Dishcraft Robotics aims to transform the food service industry through the integration of robotics, artificial intelligence, and innovative mechanical design.

Matterport is a spatial data company specializing in the digitization and indexing of the built environment. Its comprehensive 3D data platform enables users to create accurate and immersive digital twins of physical spaces. These digital representations can be utilized for various purposes, including design, development, operation, promotion, and analysis of environments. The company generates revenue primarily through subscription fees from customers who access its platform, along with income from licenses, services, and product sales. Matterport's innovative approach facilitates a deeper understanding of spaces, making it a valuable tool for industries such as real estate, architecture, and construction.

ThruWave specializes in millimeter wave imaging technology, catering to various commercial and industrial sectors such as robotics, construction, and quality control. Founded in 2017 and based in Seattle, Washington, the company offers low-cost sensors that leverage patent-pending radar signal processing and GPU-accelerated image reconstruction techniques. ThruWave's technology enhances operational efficiency by allowing construction professionals to visualize the internal structures of walls, ceilings, and floors, thereby reducing risks and expediting workflows. Additionally, its solutions support inventory verification, shipment confirmations, and detection of packaging issues, enabling clients to automate processes such as counting contents and identifying damaged or missing items.

Avail Medsystems, Inc. is a digital healthcare company that develops a platform designed to remotely connect healthcare experts with practitioners. The company's integrated audio/visual hardware and software system facilitates procedural support, observation, and clinical education services, allowing healthcare professionals to collaborate effectively. By enabling real-time access to clinical expertise, Avail aims to eliminate physical, economic, and logistical barriers in the healthcare industry. This approach promotes innovation and enhances the adoption of medical tools and techniques, ultimately improving patient care. Founded in 2017 and based in Palo Alto, California, Avail Medsystems was previously known as Nurep, Inc. and underwent a name change in March 2018.

Figur8, Inc. is a Boston-based company that specializes in developing advanced wearable sensors to monitor body movement as a biomarker for musculoskeletal (MSK) conditions. Founded in 2016 as a spin-off from MIT, Figur8 combines smart biosensors, intuitive software, and artificial intelligence to analyze MSK health data. The technology captures three-dimensional skeletal movement and muscle output, allowing for objective assessment of musculoskeletal performance and recovery. This innovative solution provides valuable insights throughout the entire care process, from injury to full recovery, ultimately reducing healthcare costs, improving access to treatment, and empowering patients to manage their own MSK health effectively.

Instrumental, Inc. specializes in developing software that enhances the efficiency of assembly lines by enabling them to autonomously operate, learn, and adapt. This innovative approach significantly reduces scrap and rework costs for manufacturers, allowing them to address issues promptly and maintain higher production yields. The company's solutions are implemented in various global assembly lines, particularly among leading manufacturers. Founded by former Apple engineers Anna-Katrina Shedletsky and Samuel Weiss, Instrumental aims to revolutionize the manufacturing industry by transforming inefficiencies into opportunities. In addition to its software offerings, Instrumental provides a range of services including performance analysis, architecture and design, and management consulting, catering to both commercial clients and government agencies. Based in Saint Paul, Minnesota, Instrumental has been active since 1991, focusing on creating impactful technological advancements in data-intensive environments.

OPT Industries is a digital manufacturing company founded in 2019 by Jifei Ou in Cambridge, Massachusetts. The company specializes in designing and mass-producing precision-engineered products at the micron scale, leveraging a combination of advanced machinery, software, and design expertise. OPT Industries offers its clients the ability to develop innovative product concepts and efficiently transition them to commercialization with rapid and scalable production capabilities. By providing high-quality products with shortened lead times, the company caters to globally recognized brands seeking to enhance their offerings through precision manufacturing solutions.

CytoVale, Inc. is a medical technology company based in San Francisco, California, established in 2012. The company specializes in developing biomarkers that leverage the mechanical properties of individual cells, a field known as mechanomics. By utilizing microfluidics technology, CytoVale can efficiently route and physically probe single cells to measure multiple biomarkers simultaneously. This innovative approach aims to enhance early detection of immune-mediated diseases, particularly sepsis, thereby improving patient outcomes and reducing treatment costs. CytoVale's integration of cell mechanics with machine learning positions it at the forefront of revolutionizing diagnostic practices in healthcare.

Plotlogic is a global technology company focused on enhancing the efficiency of mine operations through advanced AI and sensor-driven solutions. Its yield uplift platform provides real-time, autonomous, and non-invasive characterization of raw materials, allowing mine operators to accurately assess the location and properties of every rock within a mine. This technology enables clients to improve ore recovery, minimize dilution, and reduce operational costs while also decreasing carbon emissions and environmental impact. By delivering precise insights into mineral composition and location, Plotlogic supports the critical mineral industry in maximizing yield and sustainability.

Flex Logix, founded in 2014 and based in Mountain View, California, specializes in semiconductor and software solutions that enable the embedding of field-programmable gate arrays (FPGAs) of various sizes within integrated circuits. The company's innovative technology allows chips to change their configuration even after they have been shipped, providing chip designers with the flexibility to reprogram essential register-transfer levels at any time. Flex Logix generates revenue through licensing fees for design files and tools, an annual fee for the ongoing use of its EFLX Compiler, and royalties based on usage.

Momentus Inc. is a commercial space company based in Santa Clara, California, founded in 2017. The company specializes in providing water-powered transportation services for spacecraft and aims to offer a range of in-space infrastructure services. These services include in-space transportation, hosted payloads, and in-orbit servicing, facilitated by its planned transfer and service vehicles. Momentus is developing an innovative water plasma-based propulsion system to enable efficient movement of satellites and payloads between orbits. By focusing on space transportation, satellite services, and in-orbit servicing, Momentus positions itself as a key player in the evolving space economy.

Particle provides hardware and software tools to help users prototype, scale, and manage IoT products. Particle is an IoT device platform that enables businesses to easily add the power of connectivity to any product. From hardware to connectivity to device management and cloud, Particle provides developers with tools to prototype IoT solutions quickly as well as a reliable and secure platform for enterprises to scale. Over 150,000 product builders in more than 170 countries and half of the Fortune 500 have deployed connected IoT devices powered by Particle. Listed as one of Fast Company’s Most Innovative Companies of 2015 and named as a major player to watch in the IoT Landscape in IDC Marketscape’s 2018 Vendor Assessment, Particle’s customers include NASA, SpaceX, consumer hot tub manufacturer Jacuzzi, and coffee-brewing pioneer Keurig. Venture backed by Root Ventures, Spark Capital, and Qualcomm Ventures. Particle is based in San Francisco, CA and Shenzhen, China. Particle was founded on 2012.

Avail Medsystems, Inc. is a digital healthcare company that develops a platform designed to remotely connect healthcare experts with practitioners. The company's integrated audio/visual hardware and software system facilitates procedural support, observation, and clinical education services, allowing healthcare professionals to collaborate effectively. By enabling real-time access to clinical expertise, Avail aims to eliminate physical, economic, and logistical barriers in the healthcare industry. This approach promotes innovation and enhances the adoption of medical tools and techniques, ultimately improving patient care. Founded in 2017 and based in Palo Alto, California, Avail Medsystems was previously known as Nurep, Inc. and underwent a name change in March 2018.

Optimus Ride is a self-driving vehicle company located in Boston, Massachusetts, specializing in the development of technologies aimed at creating efficient, sustainable, and equitable mobility systems. As a spinoff from MIT, the company leverages over 30 years of interdisciplinary research in self-driving technologies, electric vehicles, and mobility-on-demand systems. Its team possesses extensive industrial and entrepreneurial expertise, encompassing areas such as manufacturing robots, urban design, and shared vehicle fleet management. Optimus Ride focuses on implementing self-driving technology in geofenced environments, utilizing advancements in sensor fusion, mapping, computer vision, and machine learning. This enables a wide range of transportation solutions, from commercial vessel operations to various transit options.

Figur8, Inc. is a Boston-based company that specializes in developing advanced wearable sensors to monitor body movement as a biomarker for musculoskeletal (MSK) conditions. Founded in 2016 as a spin-off from MIT, Figur8 combines smart biosensors, intuitive software, and artificial intelligence to analyze MSK health data. The technology captures three-dimensional skeletal movement and muscle output, allowing for objective assessment of musculoskeletal performance and recovery. This innovative solution provides valuable insights throughout the entire care process, from injury to full recovery, ultimately reducing healthcare costs, improving access to treatment, and empowering patients to manage their own MSK health effectively.

Fauna Bio Incorporated is a biotechnology company based in San Francisco, California, founded in 2018. It specializes in developing a cross-mammal drug discovery platform aimed at treating human diseases, including heart disease and neurodegenerative disorders. By studying the mechanisms that allow certain animals, such as hibernating and deep-diving species, to withstand extreme conditions, Fauna Bio seeks to uncover insights that can enhance human health. The company utilizes animal genomics, transcriptomics, metabolomics, and proteomics data from a diverse range of species to identify novel drug targets and facilitate pre-clinical and early clinical testing of new therapeutics. Through its innovative approach, Fauna Bio aims to improve recovery from serious medical events like trauma, heart attacks, and strokes.

nTopology, Inc. is an engineering software company that develops tools for manufacturing, focusing on design, simulation, and advanced manufacturing processes. Its flagship product, nTopology, allows engineers to create lightweight and optimized parts tailored to their functional requirements. The platform includes features such as Lightweighting, Architected Materials, Topology Optimization, Additive Manufacturing, and Design Analysis, which help eliminate geometry bottlenecks and enhance collaboration among teams. nTopology serves various industries, including aerospace and defense, medical, automotive, consumer products, and education. Founded in 2013 and headquartered in New York, the company aims to streamline workflows and integrate synthesized geometry with simulation data to produce manufacturing-ready models.

Nautilus Labs Inc. develops a platform that offers analytical solutions for maritime transportation, focusing on real-time data unification, verification, and analysis. This technology aids operators in making informed business decisions through features like TrueVoyage, which continuously provides critical reporting values and enables constant monitoring of ship performance. The platform caters to various sectors, including gas carriers, tankers, container ships, bulk carriers, and roro. Founded in 2016 and based in New York, Nautilus Labs also emphasizes decarbonization within the ocean supply chain by applying machine learning to enhance predictive decision-making for fleet efficiency. Their solutions are integrated with clients’ workflows and are supported by human-centric change management programs to ensure successful organizational adoption.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company based in Salt Lake City, Utah, that focuses on revolutionizing drug discovery through the integration of advanced technologies such as artificial intelligence, automation, and bioinformatics. Founded in 2013, the company has developed a comprehensive drug discovery platform that includes various tools and software, such as ReChem for chemical compound design, ReScreen for managing complex experimental workflows, and RePredict for modeling drug relationships using machine learning. These innovations enable Recursion to generate extensive biological and chemical datasets, facilitating the exploration of foundational biology and accelerating the development of new therapeutic solutions. Through its unique approach, Recursion aims to significantly enhance patient outcomes and streamline the drug discovery process.

Immusoft Corporation is a biotechnology company focused on developing an autologous cell therapy platform aimed at treating a range of human diseases through its proprietary Immune System Programming (ISP) technology. Founded in 2009 and based in Seattle, Washington, Immusoft specializes in modifying the DNA of a patient's immune cells to create biofactories capable of producing gene-encoded medicines, including essential proteins and enzymes that may be missing or defective. The company's innovative approach involves reprogramming B cells, a type of immune cell, which enables them to manufacture and secrete various antibodies. This process not only provides a potential long-term solution for patients but also positions Immusoft at the forefront of biotechnology in addressing rare and infectious diseases.

CytoVale, Inc. is a medical technology company based in San Francisco, California, established in 2012. The company specializes in developing biomarkers that leverage the mechanical properties of individual cells, a field known as mechanomics. By utilizing microfluidics technology, CytoVale can efficiently route and physically probe single cells to measure multiple biomarkers simultaneously. This innovative approach aims to enhance early detection of immune-mediated diseases, particularly sepsis, thereby improving patient outcomes and reducing treatment costs. CytoVale's integration of cell mechanics with machine learning positions it at the forefront of revolutionizing diagnostic practices in healthcare.